Myriad Genetics, Inc. (MYGN)
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Employees
Number of Employees: 994
Revenue per Employee: $202,652
Corporate Structure
CHIEF EXECUTIVE OFFICER
Peter D. Meldrum
TOP EXECUTIVES
Dr. Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc.
Dr. Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc.
Dr. Mark H. Skolnick, Ph.D. Chief Scientific Officer and Director
Dr.Dennis Langer, M.D., J.D. Director
Robert S. Attiyeh Director
Dr. Walter Gilbert, Ph.D. Vice Chairman of the Board
Dr. Linda S. Wilson, Ph.D. Director
Dr. John T. Henderson, M.D. Chairman of the Board
William A. Hockett, III Executive Vice President, Corporate Communications
Dr. Jerry S. Lanchbury, Ph.D. Executive Vice President, Research
Richard M. Marsh, Esq. Executive Vice President, General Counsel and Secretary
W. Wayne Laslie Chief Operating Officer, Myriad Pharmaceuticals, Inc.
Mark C. Capone Chief Operating Officer, Myriad Genetic Laboratories, Inc.
James S. Evans Chief Financial Officer and Treasurer
Gerald P. Belle Director
Robert G. Harrison Chief Information Officer
